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BACKGROUND: Although styrene is an established neurotoxicant at occupational exposure levels, its neurotoxicity has not been characterized in rela-
tion to general population exposures. Further, occupational research to date has focused on central nervous system impairment.
OBJECTIVE:We assessed styrene-associated differences in sensory and motor function among Gulf coast residents.
METHODS:We used 2011 National Air Toxics Assessment estimates of ambient styrene to determine exposure levels for 2,956 nondiabetic Gulf state
residents enrolled in the Gulf Long-term Follow-up Study, and additionally measured blood styrene concentration in a subset of participants 1 to 2 y
after enrollment (n=310). Participants completed an enrollment telephone interview and a comprehensive test battery to assess sensory and motor
function during a clinical follow-up exam 2 to 4 y later. Detailed covariate information was ascertained at enrollment via telephone interview. We
used multivariate linear regression to estimate continuous differences in sensory and motor function, and log-binomial regression to estimate preva-
lence ratios for dichotomous outcomes. We estimated associations of both ambient and blood styrene exposures with sensory and motor function, in-
dependently for five unique tests.
RESULTS: Those participants in the highest 25% vs. lowest 75% of ambient exposure and those in the highest 10% vs. lowest 90% of blood styrene
had slightly diminished visual contrast sensitivity. Mean vibrotactile thresholds were lower among those in the highest vs. lowest quartile of ambient
styrene and the highest 10% vs. lowest 90% of blood styrene (−0:13 log microns; 95% CI: −0:23, −0:03 and −0:39 log microns; 95% CI: −0:72,
−0:05, respectively). The highest vs. lowest quartile of ambient styrene was associated with significantly poorer postural stability, and (unexpectedly)
with significantly greater grip strength.
DISCUSSION:We observed associations between higher styrene exposure and poorer visual, sensory, and vestibular function, though we did not detect
associations with reduced voluntary motor system performance. Associations were more consistent for ambient exposures, but we also found notable
associations with measured blood styrene. https://doi.org/10.1289/EHP3954
Introduction
Styrene [also known as ethenylbenzene, chemical formula C8H8
(or, more precisely, C6H5CH=CH2), Chemical Abstract Service
(CAS) number 100-42-5] is a hydrocarbon used in plastics, fiber-
glass, rubber, and resins. It is used to manufacture products such as
insulation, fiberglass boats, automotive parts, car tires, Styrofoam,
and plastic drinking glasses (ATSDR 2010). After the disposal of
styrene-based products, styrene is released primarily into air,
though smaller amounts are detected in soil and water (ATSDR
2012). Ambient styrene, a volatile organic compound, breaks
down in the atmospherewithin 1 to 2 d (ATSDR2010).
The general population is exposed to styrene primarily through
inhalation of tobacco smoke, off-gassing of building materials, and
vehicle and industrial emissions (ATSDR 2011; U.S. EPA 1994).
The principal route of styrene exposure is through inhalation of
contaminated air (ATSDR 2010). Typically, indoor air contains
higher styrene levels than outdoor air (Wallace 1986) due to emis-
sions from building materials, consumer products, and tobacco
smoke (CDC 2009). Emissions from industrial activities andmotor
vehicle exhaust are the primary sources of styrene in outdoor air.
The half-life of styrene in blood is approximately 13 h, so blood
styrene levels reflect recent exposure. Approximately 40% of theU.S.
adult population has measurable levels of styrene in their blood
(Bonanno et al. 2001; CDC2009).
Although the occupational styrene literature has focused on cen-
tral nervous system toxicity (ATSDR 2010), the peripheral nervous
system may be another critical target for styrene’s neurotoxic
effects, particularly at environmental levels. The peripheral nervous
system is composed of multiple nerve fiber populations, including
long, large-diameter, heavily myelinated neurons with limited toler-
ance to physiological and toxicological insult. Therefore, portions
of the peripheral nervous system may be more vulnerable to small
perturbations, resulting in impaired peripheral nerve performance
earlier, and at lower exposure levels, than are other neurologic
tissues.
Low-level, chronic styrene exposure may affect neurologic
function at environmental levels relevant to the general popula-
tion (Cohen et al. 2002). The Gulf States are home to over half of
all U.S. styrene production (ATSDR 2010; NTP 2014), as well as
to many industrial and manufacturing facilities that use and emit
styrene in the production of plastics, rubber, and fiberglass. This
geographic clustering of industries potentially exposes Gulf resi-
dents to disproportionately high environmental styrene emissions
from petrochemical, manufacturing, and coastal fishing and boat-
ing operations (Helper et al. 2012). We investigated associations
between environmental styrene exposure, assessed as both blood
and air concentrations, and sensory and motor function.
Methods
Study Design and Participants
The Gulf Long-term Follow-up Study (GuLF STUDY) is a pro-
spective cohort of adults (age 21 and older) who participated in
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oil spill response activities and others who received safety train-
ing but were not hired, following the Deepwater Horizon disaster
(Engel et al. 2017; Kwok et al. 2017). Participants enrolled in the
GuLF STUDY between March 2011 and March 2013
(N =32,608). All GuLF STUDY cohort participants living in the
Gulf region who spoke English or Spanish were invited to partici-
pate in a home visit. Ultimately, 11,193 home visits were com-
pleted between May 2011 and May 2013. A subset of home visit
participants (n=1,055) enrolled in a Chemical Biomonitoring
Study (CBS) between May 2012 and July 2013 (Werder et al.
2017). The CBS initially oversampled for nonsmokers, women,
and Deepwater Horizon clean-up workers. To reach the target
sample size before the end of the home visit period of the GuLF
STUDY, recruitment efforts were later expanded to include all
home visit participants. Participation in the CBS involved provid-
ing an extra blood sample for measuring styrene and other com-
pounds and completing a questionnaire about usual and recent
exposures and relevant activities. Because styrene is rapidly
cleared from the body and blood measurements were obtained 2
to 3 y after the oil spill, these levels represent usual, ongoing
exposures (i.e., they are not due to oil spill cleanup work).
A subset of GuLF STUDY participants (n=3,403) residing
within approximately 60miles of study clinics in New Orleans,
Louisiana, and Mobile, Alabama, were recruited for a follow-
up clinical examination between August 2014 and July 2016.
Participation involved completing a clinical examination in one
of the two clinics. Examinations included anthropometric meas-
urements, biological sample collection, standardized computer-
assisted neurocognitive testing, sensory and motor function
evaluations, pulmonary function testing, and interviews on
mental health and other factors.
Of the 3,403 participants who completed the follow-up clini-
cal exam, 3,329 (98%) reported addresses at enrollment that were
successfully geocoded to a 2010 U.S. Census Bureau census
tract. From this sample of participants with known residential
locations, we excluded anyone with missing outcome information
for all five sensory and motor function tests (n=8), missing de-
mographic information (n=37), or missing covariate information
(n=22). Of the remaining 3,262 participants with complete ex-
posure, outcome, and covariate information, we restricted analy-
ses to participants with no self-reported physician diagnosis of
diabetes (i.e., we excluded 303 diabetics and 3 participants miss-
ing diagnosis information) because neuropathy is a known com-
plication of diabetes (Freeman 2014). These exclusions resulted
in a final analytic sample of 2,956.
A total of 348 CBS participants with blood samples sufficient
for quantification of styrene concentration also participated in the
follow-up clinical examination. Of those participants, we excluded
five participants missing all sensory and motor function informa-
tion. The remaining 343 participants had complete exposure, out-
come, demographic, and covariate information. We then excluded
known diabetics (n=33), for a final analytic sample of 310.
Participants provided written informed consent and the
Institutional ReviewBoard of theNational Institute of Environmental
HealthSciences approved this study.
National Air Toxics Assessment (NATA)
The United States Environmental Protection Agency (EPA) 2011
National Air Toxics Assessment (NATA) (U.S. EPA 2016) esti-
mates annual average ambient air toxic concentrations for each
U.S. Census tract. NATA evaluates 180 air toxics across the
United States using emissions inventories; dispersion, photo-
chemical, and exposure modeling; and toxicity analyses. We
used NATA styrene estimates to indicate typical long-term envi-
ronmental exposure by geocoding self-reported home addresses
at enrollment, mapping each participant’s location, and matching
them to a corresponding 2010 U.S. Census tract. The 2011
NATA annual average ambient styrene concentration (lg=m3)
corresponding to an individual’s home census tract was applied
as the estimate of usual ambient styrene exposure.
Blood Styrene Measurement
We collected 10 mL of blood for styrene measurement using tubes
containing potassium oxalate and sodium fluoride anticoagulant;
tubes and stoppers were pretreated by the Centers for Disease
Control and Prevention (CDC) laboratory to remove volatile or-
ganic compounds (VOCs) to minimize precollection contamina-
tion (Chambers et al. 2005; Chambers et al. 2008). Samples were
stored at 4°C until being shipped overnight on cold packs in
biweekly batches to the Division of Laboratory Sciences, National
Center for Environmental Health, CDC, in Atlanta, Georgia, for
analysis of VOCs. Styrene was analyzed using equilibrium head-
space solid-phasemicroextractionwith benchtop gas chromatogra-
phy/mass spectrometry following standard CDC procedures
(Blount et al. 2006; Chambers et al. 2006).
Sensory and Motor Function Testing
The sensory and motor function testing battery, which was used
in an earlier study of chronic, low-level neurotoxicants (Starks
et al. 2012), included tests of visual acuity, visual contrast sensi-
tivity, handgrip strength, vibrotactile threshold, standing steadi-
ness, and single leg stance. These tests evaluate sensory and
motor functions corresponding to neurotoxic effects that have
been demonstrated in association with occupational solvent expo-
sure (Campagna et al. 1995; Letz et al. 1994).
Visual acuity, an indicator of visual sharpness or clarity, was
assessed binocularly (in both eyes simultaneously) using a standard
vision testing instrument, the Optec 1,000 (Optec, Inc.). Results
from this test were used to determine eligibility for analyses of vis-
ual contrast sensitivity. Participants with binocular visual acuity
scores of 20/50 or worse were excluded from visual contrast sensi-
tivity analyses.
Visual contrast sensitivity was evaluated with the Optec 1,000
Functional Assessment of Contrast Sensitivity test. Circular stim-
uli consisting of alternating light and dark bars were presented.
Nine stimuli of decreasing contrast were presented at each of 5 spa-
tial frequencies (1.5, 3, 6, 12, and 18 cycles per degree). The weak-
est contrast correctly identified was recorded for each spatial
frequency. Results are presented as mean differences in contrast
scores because we did not have access to the information required
to present units of luminance contrast.
Standing steadinesswas evaluatedwith theAdvancedMechanical
Technology, Inc. force platform (AMTI). Participants were instructed
to stand on the platform without moving. Standing steadiness was
measured twice with participant eyes open and twice with participant
eyes closed. The force platform and associated software capture and
store the forces applied to the platform by the participant’s feet during
each trial. The force signals are processed and plotted as a time series
of locations (path) of the participant’s center of pressure. The mean
sway speeds in millimeters per second obtained during the two eyes
open and the two eyes closed trials were used for statistical analysis of
standing steadiness.
Single leg stance was evaluated by asking the participant to
stand on one leg and maintain upright balance for 30 s (Tyson
and Connell 2009). If the participant was unable to maintain their
upright balance for the entire 30-s test interval, then the proce-
dure was repeated up to two additional times. Inability to main-
tain single leg balance was defined as a need for steadying by the
examiner to prevent falling or participant inability to comply
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with instructions to stand on only one leg for the entire 30-s test
interval (i.e., the participant placed the other foot on the ground
to prevent falling). Examiners indicated whether, and on which
attempt, the participant was able to maintain his or her balance
for the entire 30-s test interval. We modeled the outcome for sin-
gle leg stance as inability to maintain upright balance for 30 s.
Vibrotactile sensory acuity was evaluated using a portable
Vibratron II electromechanical vibrometer at a frequency of
120Hz (Physitemp, Inc.). Calibration of all vibrometer devices
was conducted using a single NIST-traceable piezoelectric accel-
erometer (Model SEN021F, PCB Piezotronics). The vibrometer
devices are internally adjustable and were calibrated so that each
produced known and equal vibration amplitudes at specific values
over the full range of displayed “vibration units.” Examiners
manually controlled the delivered vibration amplitude, obtaining
five vibration threshold values (three descending and two ascend-
ing values) for each great toe (ventral surface). After discarding
the first value, the final vibrotactile threshold for each toe was the
median obtained from the remaining four values, which was con-
verted to log microns of peak-to-peak amplitude displacement for
statistical analysis.
Handgrip strength was assessed with a baseline digital hydrau-
lic hand dynamometer that records the maximum force exerted by
the participant’s whole-hand grip. Using standard hand and arm
positions, participants performed three grip strength measures for
each hand (Mathiowetz et al. 1984). We used the bilateral mean of
all six tests, measured in pounds, as the summary metric in statisti-
cal analyses.
Statistical Analysis
We used multivariate linear regression to estimate continuous dif-
ferences in sensory andmotor function per unit change in the expo-
sure metrics (ambient styrene, ba and blood styrene, bb). For ease
of interpretation, higher values indicate better performance for all
continuous outcomes (mean contrast sensitivity score, vibrotactile
threshold, handgrip strength, and postural sway speed). To achieve
this internal consistency, wemultiplied the raw values for vibrotac-
tile threshold and postural sway speed by negative one. For tests of
contrast sensitivity, we compared styrene-exposed with unexposed
participants and evaluated differences in adjusted mean scores
(adjustment covariates reported below) between exposure groups
at each spatial frequency. We used log-binomial regression to esti-
mate prevalence ratios (ambient, PRa and blood, PRb) and corre-
sponding 95% confidence intervals (95% CI) for single leg stance.
PRs above 1 indicate poorer test performance (i.e., inability to
maintain balance for the full 30 s), and PRs below 1 indicate better
test performance.
We analyzed each exposure type (i.e., NATA-estimated ambi-
ent styrene concentration and measured blood styrene concentra-
tion) separately using identical statistical methods for both. For
associations with ambient styrene (N =2,956), apart from visual
contrast sensitivity, concentrations were categorized in quartiles,
with the lowest quartile (≤0:01lg=m3) designated as the referent
group. For visual contrast sensitivity, we compared the highest
quartile with the lower three quartiles combined. In addition to
estimating associations with quartiles of ambient exposure, we
evaluated exposure–response relationships using Wald tests of
linear trend in adjusted models. For trends tests, we modeled ex-
posure as an ordinal variable with integer scores for each quartile
and reported corresponding p-values (p-trend).
For analyses of measured blood styrene (n=310), exposure was
dichotomized at the 90th percentile of the distribution, defining the
top decile of blood measurements (0:83–3:03 ng=mL) as exposed
and the remaining 90% as ‘unexposed’ (0:011− <0:83 ng=mL).
For all tests, we additionally modeled blood styrene as the top
quartile (“exposed,” ≥0:19 ng=mL) in comparison with the
three lower quartiles (“unexposed,” 0:011–<0:19 ng=mL). We
used all measured blood styrene values, including the actual values
below the limit of detection (LOD=0:03 ng=mL) (Whitcomb and
Schisterman 2008).
All models were adjusted for gender (female vs. male), age
(continuous years), race (white, black, other), education (less than
high school or equivalent, high school or general equivalency
diploma, some college or two-year degree, four-year college grad-
uate or more), employment status (self-reported currently working
vs. currently not working), alcohol consumption (any drinks in the
past 12 months vs no drinks in the past 12 months), and smoking
status (current vs. former or never). Participants were asked to
report which racial category they considered themselves to be
members of, choosing from: American Indian or Alaskan Native,
Asian, Black or African American, Native Hawaiian or Pacific
Islander, White, or Other. Based on the distribution of responses
and heterogeneity among specified “other” responses, we catego-
rized participants as white, black, or other. Because participants
identifying as Hispanic represented only 2% of the study popula-
tion for both ambient and blood styrene analyses, we did not define
race with regard to ethnicity, instead adjusting for race only.
Covariate information was obtained during the enrollment inter-
view, and adjustment covariates were selected based on relations
among different variables and a directed acyclic graph (DAG)
(Greenland et al. 1999) of the theoretical relationship between
styrene exposure and sensory and motor function (Figure S2).
For analyses of vibrotactile threshold and handgrip strength, we
additionally adjusted for height. For visual contrast sensitivity,
we restricted analyses to participants with better than 20/50 vis-
ual acuity and additionally adjusted for use of vision correction
(i.e., wearing glasses or corrective lenses). Owing to concerns
about overwhelming population variance in the handgrip strength
tests, we also examined the influence of weight and gender on
these associations.
In sensitivity analyses, we adjusted models for participation in
the Deepwater Horizon oil spill response or cleanup (≥1 day vs.
none) to account for potential fundamental differences between
cleanup workers and nonworkers. We assessed effect measure
modification using analyses stratified by age (≤45 y vs. >45 y),
sex (male vs. female), race (white, black, other), employment sta-
tus (working vs. not working), and residential location (urban vs.
rural). Interaction p-values (p-interaction) were derived from mul-
tivariate analysis of variance usingF-tests of the overall interaction
between quartiles of ambient styrene and the modifier of interest.
Due to sample size limitations, we conducted interaction analyses
for ambient exposures only.
Because eligibility criteria required that participants com-
pleted at least one sensory or motor function test from the full
battery (but not all such tests), analytic sample sizes vary between
tests.
All statistical analyses were conducted in SAS (version 9.4;
SAS Institute Inc).
Results
CBS participants, all of whom were also in the ambient analysis,
were largely similar to those in the larger study with respect to
demographic characteristics (Table 1). Approximately 70% of
participants completed their examinations at the Alabama testing
site, less than half attended college, three-fourths were male, and
about half were younger than age 45 y. Half of all participants
were white, and about 40% were black. The “other” race group
identified as Asian (7%), multiracial (38%), or various other
responses (55%) (data not shown). Among CBS participants,
85% completed all five sensory and motor function tests, in
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comparison with 81% of participants in ambient analyses. We
provide descriptive statistics on sensory and motor function in this
population, presented as mean outcomes by exposure status and
demographic group in Tables S1 and S2, respectively. Although
associations between styrene exposure and unadjusted sensory and
motor performance were not obvious (Table S1), white participants
and those younger than 45 years of age tended to perform better on
sensory and motor function tests in comparison with the older,
nonwhite counterparts (Table S2).
Because the CBS is a subpopulation completely nested within
the ambient exposure population, all participants providing blood
styrene measures also had ambient exposure estimates. Among
CBS participants, blood and ambient styrene levels lacked con-
cordance (Spearman correlation coefficient for ambient and blood
styrene, quartiles: q=0:09, p-value= 0:11; continuous: q=0:08,
p-value = 0:18). We observed similar results for continuous sty-
rene within clinical sites (Louisiana: q=0:11, p-value= 0:33;
Alabama: q= − 0:07, p-value = 0:28) and when stratifying by
smoking status (nonsmokers: q= − 0:04, p-value= 0:52; smok-
ers: q=0:16, p-value= 0:17), race (white: q= − 0:04, p-value =
0:66; nonwhite: q=0:04, p-value = 0:64), and age (<30 years:
q= − 0:15, p-value = 0:29; 30–45 y: q= − 0:11, p-value= 0:25,
>45 years: q=0:12, p-value = 0:16). To explore the relationship
between ambient and blood styrene further, we dichotomized
both metrics (air and blood styrene) at their respective medians.
We found that 90 individuals have ambient and blood styrene
Table 1. Demographic characteristics ascertained at enrollment according to estimated ambient styrene exposures in participants living in the Gulf states
(N =2,956) and blood styrene concentrations among Chemical Biomonitoring Study (CBS) participants (n=310).
Characteristic
Estimated ambient styrene
quartiles (%) (N =2,956) Blood styrene (%) (n=310)
N (%) Q1 Q2 Q3 Q4 N (%) Q1–Q3 Q4 ≤90th >90th
Clinical sitea
Louisiana 904 (31) 52 43 22 5 87 (28) 29 26 29 23
Alabama 2,052 (69) 48 57 78 95 223 (72) 71 74 71 77
Age, years
<30 463 (16) 13 14 16 19 59 (19) 18 21 18 26
30–45 1,022 (35) 29 31 36 41 110 (36) 37 31 35 35
>45 1,471 (50) 57 55 47 39 141 (46) 45 48 46 39
Raceb
White 1,520 (51) 72 58 49 26 156 (50) 51 48 51 42
Black 1,180 (40) 13 35 43 69 131 (42) 42 43 42 48
Other 256 (9) 15 7 8 5 23 (7) 7 9 7 10
Sex
Female 689 (23) 21 23 23 26 77 (25) 24 27 24 35
Male 2,267 (77) 79 77 77 74 233 (75) 76 73 76 65
Body Mass Index, kg=m2
≤Normal (<25) 782 (27) 29 27 24 26 87 (28) 25 36 28 32
Overweight (25− <30) 1,131 (38) 38 40 40 36 121 (39) 40 36 39 39
Obese (≥30) 1,043 (35) 34 33 36 39 102 (33) 35 27 33 29
Education
<High school 625 (21) 26 20 17 22 66 (21) 21 21 22 16
High school graduate 1,037 (35) 35 30 36 39 116 (37) 36 42 37 42
Some college 873 (30) 26 33 30 29 92 (30) 29 31 29 35
≥College graduate 421 (14) 13 17 17 10 36 (12) 13 6 12 6
Work statusc
Employed 1,559 (53) 57 53 52 49 165 (53) 53 53 54 48
Unemployed 1,397 (47) 43 47 48 51 145 (47) 47 47 46 52
Current drinker
Yes 2,132 (72) 71 74 75 69 215 (69) 68 73 68 84
No 824 (28) 29 26 25 31 95 (31) 32 27 32 16
Current smoker
Yes 1,009 (34) 33 36 34 34 79 (26) 22 36 24 35
No 1,947 (66) 67 64 66 66 231 (75) 78 64 76 65
Oil spill response workd
≥1 day 2,518 (85) 84 87 84 86 275 (89) 88 91 89 90
None 438 (15) 16 13 16 14 35 (11) 12 9 11 10
Vision correctione
Yes 1,220 (43) 45 43 41 41 133 (44) 42 52 44 52
No 1,647 (57) 55 57 59 59 166 (56) 58 48 56 48
Missing (N) 89 21 27 24 17 11 8 2 11 0
Poor visione
Yes 538 (19) 21 15 20 18 65 (22) 20 27 21 26
No 2,335 (81) 79 85 80 82 235 (78) 80 73 79 74
Missing (N) 83 21 25 23 14 10 8 2 10 0
Note: Enrollment occurred from March 2011 until March 2013.
aClinical exams took place at two sites: Louisiana State University in New Orleans, Louisiana and the University of Southern Alabama in Mobile, Alabama.
bParticipants were asked to report which racial category they considered themselves to be, choosing from: American Indian or Alaskan Native, Asian, Black or African American,
Native Hawaiian or Pacific Islander, White, or Other. Based on the distribution of responses and heterogeneity among specified ‘other’ responses, we categorized participants as white,
black, or other.
cWork status at enrollment: Employed, reported working; Unemployed, reported unemployed, looking for work, laid off, on leave, retired, unable to work, keeping house, student, other.
dOil spill response work includes all tasks. Participants who completed safety training, but never worked on oil spill response/cleanup are classified as ‘None’; participants who partici-
pated in any response work of any kind are classified as “≥1 day.”
eVision correction includes wearing corrective glasses and contact lenses; poor vision is definied as binocular visual acuity score 20/50 or worse; information related to vision correc-
tion and quality was only used in analyses of contrast sensitivity (nambient = 2,250; nCBS = 231). Participants missing information for vision correction and/or quality were not eligible
for contrast sensitivity analyses.
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above the median and 78 individuals have both metrics below the
median, which amounts to 54% of the CBS population.
Study end points measure different neurological functionality or
domains, but they do have some collinearity. The highest correla-
tions are between vibrotactile threshold and postural stability
(Spearman correlation coefficient, q=0:44; p-value <0:0001),
vibrotactile threshold and single leg stance (q=0:23; p-value<
0:0001), and postural stability and single leg stance (q=0:23;
p-value<0:0001). Grip strength and contrast sensitivity are less cor-
related with the other tests. The range of Spearman correlation coef-
ficients is −0:18 (for contrast sensitivity and vibrotactile threshold,
p-value<0:0001) to 0.44 (data not shown).
For ambient exposure analyses, we modeled associations for
each quartile of styrene exposure in comparison with the lowest
quartile (≤0:01lg=m3). Styrene concentrations in the highest
quartile ranged from 0.03 to 0:27lg=m3, with 95% of all meas-
urements below 0:05lg=m3 (Figure 1). For analyses of blood
styrene, we used two distinct binary exposures: one divided at the
90th percentile, 0:83 ng=mL, and one divided at the 75th percen-
tile, 0:19 ng=mL. The maximum observed concentration was
3:03 ng=mL, with 95% of participants having blood levels below
1:36 ng=mL. 24% (n=70) of participants had styrene measure-
ments below the LOD (0:03 ng=mL). The blood exposure distri-
bution demonstrated a pronounced right skew.
For tests of visual contrast sensitivity, we compared the high-
est quartile of ambient styrene with the lower three quartiles
(n=2,250). Low exposure group participants performed better
than those with high exposure at each spatial frequency, with a
significant difference (p=0:02) at 1:5 cycles=degree (Table 2).
We observed similar results for blood styrene above vs. below
the 90th percentile (n=231), though the smaller sample size
reduced precision and the only statistically significant difference
was observed at 12 cycles=degree (p=0:02). These associations
demonstrate a subtle, but consistent, decrement in visual contrast
sensitivity associated with styrene exposure across spatial
frequencies.
Increasing ambient styrene concentration was associated with
reduced vibrotactile sensitivity (n=2,888) (Figure 2).We observed a
monotonic exposure–response relationship (p-trend= 0:003), with a
significant association in the highest quartile of ambient exposure
compared to the lowest quartile (baQ4vsQ1 = − 0:13 log microns;
95% CI: −0:23, −0:03) (Table S3). For blood styrene (n=307), we
observed a nonsignificant association between the highest quartile of
exposure (in comparisonwith all others) and reduced vibrotactile sen-
sitivity (bbP75 = − 0:19 log microns; 95% CI: −0:42, 0.05;
p=0:12). When comparing the top 10% to the lower 90% of blood
styrene concentrations, this association was stronger (bbP90 = − 0:39
log microns; 95% CI: −0:72, −0:05; p=0:02) (Figure 2, Table S3).
Figure 1. Probability density of styrene concentrations in air (N =2,956) and blood (n=310). Note: Ambient styrene exposure is 2011 National Air Toxics
Assessment (NATA) modeled estimates of annual average concentrations (lg=m3) at the census-tract level. Blood styrene concentrations (ng/mL) are meas-
ured from a single blood draw obtained in the participant’s home; limit of detection= 0:03 ng=mL. Values at the top of reference lines indicate exposure con-
centrations; labels at the bottom of reference lines indicate locations in the exposure distribution: P25, 25th percentile; P50, 50th percentile; P75, 75th
percentile; P90, 90th percentile; P95, 95th percentile. Max, maximum value.
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For comparison, in the same models used to evaluate styrene expo-
sure and vibrotactile threshold, a 10-y increase in age was associated
with a −0:49 log microns (95% CI: −0:57, −0:41) and a −0:51 log
microns (95% CI: −0:54, −0:48) decrease in vibrotactile threshold
among CBS participants (n=307) and the ambient study population
(n=2,888), respectively.
Ambient styrene exposure (n=2,855) was associated with
decreased standing steadiness, with statistically significantly
worse stability at each quartile of exposure in comparison with
the lowest quartile (Figure 3, Table S3). The linear trend across
quartiles of exposure was significant when participants’ eyes
were closed (p-trend= 0:02), as well as open (p-trend<0:0001).
The highest quartile of exposure was associated with differences
in sway speed of 4:5 mm=s for both tests (baQ4vsQ1 eyes closed
and open). For comparison, a 10-y difference in age was associ-
ated with differences in sway speed of 7.4 (95% CI: 6.4, 8.3) and
4.4 (95% CI: 3.8, 4.9) mm/s for eyes closed and open, respec-
tively. Expressed alternatively, ambient exposure-related associa-
tions were equivalent to differences of 0.13 and 0.24 standard
deviations of mean sway speed for eyes closed and open, respec-
tively. In contrast, we did not detect associations in blood styrene
exposure analyses (n=299).
Styrene exposure was also positively associated with impair-
ments in single leg stance (Table S3). Participants in the highest
quartile of ambient styrene exposure were 42% more likely to ex-
perience loss of balance during the test in comparison with the
participants in the lowest quartile (PRaQ4vsQ1 = 1.42; 95% CI:
1.17, 1.71), and those with blood measurements above the 90th
percentile were twice as likely to lose their balance in comparison
with all others (PRbP90 = 2.07; 95% CI: 1.18, 3.61).
Unexpectedly, handgrip strength improved with increasing
ambient styrene exposure (n=2,930), demonstrating a significant
linear trend (p-trend<0:0001). Higher exposure groups (i.e., the
third and fourth quartile in comparison with the first quartile)
were associated with increases of approximately six pounds of
force (Table S3, Figure S1). We did not observe associations
between blood styrene exposure and handgrip strength (n=310).
Handgrip strength results were robust to additional adjustment
for weight (Table S4).
Overall, patterns of effect measure modification were not
obvious (Tables S5–S10). We did not observe any heterogeneity
of associations by sex for any of the end points (Table S5).
Although results were generally similar between white and black
participants, associations were stronger among those classified as
“other” for grip strength (baQ4vsQ1 = 24:9; 95% CI: 13.8, 35.9 vs.
4.6; 95% CI: −0:6, 9.9 and 1.2; 95% CI: −6:1, 8.4, respectively,
p-interaction= 0:01) and single leg stance (PRaQ4vsQ1 = 2:2; 95%
CI: 1.2, 4.0 vs. 1.2; 95% CI: 0.9, 1.6 and 1.3; 95% CI: 0.9, 2.0,
respectively, p-interaction= 0:04) (Table S6). Impairments in
standing steadiness were more pronounced in participants older
than age 45 for the highest exposure group (baQ4vsQ1 = − 7:0;
95% CI: −10:8, −3:2) in comparison with younger participants
Table 2. Ambient (n=2,250) and blood (n=231) styrene concentrations and differences in visual contrast sensitivity performance.
Range
Ambient, Q4 vs. Q1–Q3 Blood, Q4 vs. Q1–Q3 Blood, Top 10% vs. Lower 90%
Mean difference (95% CI) p-Value Mean difference (95% CI) p-Value Mean difference (95% CI) p-Value
1.5 0.11 (0.02, 0.21) 0.02 0.14 (−0:14, 0.42) 0.33 0.12 (−0:29, 0.52) 0.58
3 0.10 (−0:001, 0.19) 0.05 0.26 (−0:05, 0.56) 0.10 0.31 ( −0:14, 0.75) 0.17
6 0.02 (−0:13, 0.16) 0.83 −0:16 (−0:58, 0.25) 0.44 0.36 (−0:25, 0.96) 0.25
12 0.14 (−0:01, 0.30) 0.07 0.28 (−0:21, 0.77) 0.26 0.82 (0.11, 1.52) 0.02
18 0.09 (−0:06, 0.24) 0.22 0.05 (−0:39, 0.49) 0.81 0.60 (−0:03, 1.24) 0.06
Note: Models adjusted for vision correction, gender, age, race, education, enrollment employment status, enrollment drinking status, and enrollment smoking status. Restricted to par-
ticipants with normal visual acuity (better than 20/50). Mean difference, difference in mean scores between high and low exposure groups; p-value for difference in means between
high and low exposure groups; positive values indicate worse performance in high-exposure groups. Range, spatial frequency (cycles/degree). Q4, fourth quartile; Q1–Q3, first through
third quartile. Top 10%, blood concentrations exceeding 90th percentile. Ambient styrene exposure is 2011 National Air Toxics Assessment (NATA) estimates of annual average con-
centrations (lg=m3) at the census-tract level. Blood styrene concentration (ng/mL).
Figure 2. Ambient (n=2,888) and blood (n=307) styrene concentrations and differences in vibrotactile threshold. Note: Symbol markers and labels indicate
change in vibrotactile threshold multiplied by −1 (log microns); negative values reflect sensory deficits; error bars indicate 95% confidence intervals (CI).
Models adjusted for gender, age, height, race, education, enrollment employment status, enrollment drinking status, and enrollment smoking status. Ambient
styrene exposure is 2011 National Air Toxics Assessment (NATA) estimates of annual average concentrations (lg=m3) at the census-tract level. Q1, first quar-
tile (referent exposure group); Q2, second quartile; Q3, third quartile; Q4, fourth quartile. Blood styrene concentration (ng/mL): Top 10% vs. Lower 90%, com-
pares measurements in the highest decile to the rest of the distribution; Q4 vs. Q1–Q3, compares measurements in the highest quartile to the rest of the
distribution. Numeric data provided in Table S3.
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(baQ4vsQ1 = − 1:9; 95% CI: −3:5, −0:2), but age-associated dif-
ferences did not persist for the third quartile of ambient styrene
(p-interaction= 0:08) (Table S7). Associations between the high-
est quartile of ambient styrene and single leg stance were stronger
in the unemployed (PRaQ4vsQ1 = 1:6; 95% CI: 1.2, 2.0) than in
employed participants (PRaQ4vsQ1 = 1:2; 95% CI: 0.9, 1.7)
(p-interaction= 0:05) (Table S8). Point estimates for single leg
stance were higher in the rural (PRaQ4vsQ1 = 1:9; 95% CI: 1.4,
2.7) than in the urban participants (PRaQ4vsQ1 = 1:2; 95% CI: 0.9,
1.6) population (p-interaction= 0:01), but there was no evidence
of heterogeneity by urban or rural location for other tests of balance
(standing steadiness, p-interaction= 0:54) (Table S9). Adjustment
for participation in Deepwater Horizon oil-spill response or cleanup
did not change results (Tables S11 and S12).
Discussion
Our study of styrene-associated neurotoxicity investigated environ-
mental exposure levels in relation to five measures of sensory and
motor function. We observed styrene-associated impairment in vis-
ual sensitivity, sensory acuity, and postural function, though we did
not detect evidence of impaired voluntary motor system perform-
ance. Differences in sensory performance were generally more con-
sistent in relation to ambient styrene exposure, but we also
observed associations with measured blood styrene concentration.
Taken together, stratified analyses did not reveal patterns of hetero-
geneity in associations between styrene exposure and sensory or
motor function.
When comparing mean visual contrast sensitivity scores between
exposure groups across spatial frequencies,we observedmodest asso-
ciations, some of which achieved statistical significance. Overall,
however, a consistent pattern emerged, revealing decrements in visual
contrast sensitivity associated with higher ambient and blood styrene
concentration. Some investigations of occupational styrene exposure
among fiberglass plastic workers have also reported diminished con-
trast sensitivity (Campagna et al. 1995; Castillo et al. 2001), although
others found no exposure-related effects (Mergler et al. 1996; Seeber
et al. 2009b). Occupational exposure to organic solvents, generally,
has been shown to affect visual contrast sensitivity (Costa et al. 2012),
but the occupational styrene literature has emphasized loss of color
vision specifically (Campagna et al. 1996; Castillo et al. 2001; Gobba
et al. 1991; Iregren et al. 2005;Kishi et al. 2001).
We observed impairments in vibrotactile threshold associated
with blood styrene concentration, as well as a significant monotonic
exposure–response trend across increasing quartiles of ambient sty-
rene exposure. For both exposure types, significant associations
were observed among participants in the highest exposure groups
(i.e., for blood styrene, the top 10% in comparison with all others,
and in ambient styrene, the highest quartile in comparison with the
lowest quartile). For comparison, the estimated decrement in
Figure 3. Ambient (n=2,855) and blood (n=299) styrene concentrations and differences in standing steadiness. Symbol markers and labels indicate change in
sway speed (mm/s) multiplied by −1; negative values reflect sensory deficits; error bars indicate 95% confidence intervals (CI). Models adjusted for gender,
age, race, education, enrollment employment status, enrollment drinking status, and enrollment smoking status. Ambient styrene exposure is 2011 National Air
Toxics Assessment (NATA) estimates of annual average concentrations (lg=m3) at the census-tract level. Q1, first quartile; Q2, second quartile; Q3, third quar-
tile; Q4, fourth quartile. Blood styrene concentration (ng/mL): Top 10% vs. Lower 90%, compares measurements in the highest decile to the rest of the distribu-
tion; Q4 vs. Q1-Q3, compares measurements in the highest quartile to the rest of the distribution. Numeric data provided in Table S3.
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vibrotactile threshold associated with a 10-y age difference was
greater than styrene-associated decrements, although the magnitude
was comparable between a decade of aging and the highest decile of
blood styrene exposure. As such, our results provide evidence of
styrene-associated decreases in somatosensory function.
Measurement of cutaneous vibrotactile threshold is an estab-
lished, sensitive, and well-validated test of peripheral neurologic
performance in a variety of settings (Gerr and Letz 1993).
Cutaneous vibrotactile threshold testing assesses the integrity of
the entire somatosensory pathway from cutaneous receptor to
somatosensory cortex, including the peripheral sensory nerves.
Cutaneous vibratory stimuli are carried on large, heavily myelin-
ated, sensory nerve fibers, which are believed to be more suscepti-
ble than small myelinated and unmyelinated fibers are to both
systemic and focal insult. Furthermore, longer nerve fibers such as
those innervating the toe are more susceptible to physiological
insult than are shorter fibers innervatingmore proximal anatomical
sites.Although this specific end point has not been widely eval-
uated in the styrene literature, some studies of workers exposed to
styrene have found exposure-related adverse peripheral neurologi-
cal effects when assessed with vibrotactile thresholds (Sato et al.
2009) as well as conventional electrophysiological testing of pe-
ripheral nerve conduction parameters (Murata et al. 1991; Yuasa
et al. 1996). The literature is inconsistent, however, with other
studies failing to observe associations between styrene exposure
and electrophysiological outcomes (Triebig et al. 1985). The litera-
ture does not provide evidence for a specific histopathological or
pathophysiological mechanism for possible effects of styrene on
neurological tissues. Finally, we are not aware of studies of neuro-
logical effects of styrene at nonoccupational exposure levels simi-
lar to the range of levels reported in this study.
Handgrip strength provides information about the functional in-
tegrity of the voluntary motor system from the motor cortex to pe-
ripheral skeletal muscles. Subchronic styrene exposure induced
impaired motor function in rats (Chakrabarti 2000; Terre’Blanche
et al. 2011), but we are not aware of such effects in humans. We
observed a paradoxical association between ambient styrene expo-
sure and grip strength, with increased styrene concentration associ-
ated with increased grip strength, whereas we observed no
associations between blood styrene concentration and grip
strength. We attribute these paradoxical findings, in part, to high
population variance of this measure. Detecting associations in the
presence of such variance would require a strong exposure effect
on the nerves being tested. Because longer nerves are typically
more susceptible than shorter nerves are to toxic exposures, associ-
ations in the expected direction might have been observed had we
been able to measure motor strength of the lower extremities.
Unfortunately, such testing was not feasible in the current study.
Tests of great-toe vibrotactile threshold and standing stability do
assess the longest peripheral nerves and are likely more sensitive
to subtle adverse effects. We attempted to account for some grip
strength variance by adjusting for body mass index and physical
activity, as well as by excluding women; however, results were
unchanged in these analyses. Another possible explanation for the
paradoxical association is residual confounding by socioeconomic
status. In our study, ambient exposure was estimated geographi-
cally and potentially covaries with socioeconomic status. Indeed, a
recent analysis of NATA 2011 data reported that census tracts
with greater proportions of nonwhite and low-income populations
are exposed to higher concentrations of ambient air toxics than
their wealthier, less diverse counterparts are exposed to (Huang
et al. 2017). In addition to potentially experiencing higher expo-
sures, people living in communities characterized by lower socio-
economic status may also be more likely to engage in labor-
intensive jobs or activities and therefore may be stronger as a
consequence of occupational physical conditioning. As such, associ-
ations between ambient styrene and handgrip strength may be con-
founded by social factors, or simply reflectmuscular training effects,
as opposed to effects on motor control systems. The lack of demon-
strated styrene-associated impairments in motor function at occupa-
tional levels, combined with these paradoxical results, suggest that
the test of grip strength may have been capturing a phenomenon dis-
tinct fromexposure-related neurotoxicity.
Tests of balance assess the integrated function of several com-
ponents of the nervous system, including the vestibular apparatus,
cerebellum, and proprioceptive system (Gerr et al. 2000). Loss of
functional integrity of any of these systems secondary to toxic ex-
posure may affect postural stability. In our study, we observed
significant associations between all quartiles of ambient styrene
exposure and decreased standing steadiness (i.e., increased
sway), with a monotonic exposure response. We did not, how-
ever, detect any associations between postural sway and blood
styrene concentration. Results for ambient styrene and inability
to maintain single leg stance were similar to those observed for
postural sway. We also observed an association between inability
to maintain single leg balance and the top 10% of blood styrene
exposure. Combined, these results suggest a potential impairment
of the motor control system necessary to balance due to environ-
mental styrene exposure. These findings are supported by a study
of reinforced plastic boat builders, which also reported impaired
postural stability in association with styrene exposure (Toppila
et al. 2006).
Styrene is an established neurotoxicant at occupational expo-
sure levels. Acute exposure causes depression of the central
nervous system with anesthesia-like properties at high exposure
levels (ATSDR 2010; IARC 2002; Tormoehlen et al. 2014).
Epidemiologic studies to date have focused on highly exposed
workers, whose average blood levels were 10–12 times higher than
those of CBS participants, and 25 times higher than the general
population (Brugnone et al. 1993; Cherry and Gautrin 1990;
Coggon 1994; Papaleo et al. 2011; Seeber et al. 2009a; Toppila
et al. 2006; Triebig et al. 1989; Vodicka et al. 1995). Occupational
studies demonstrate styrene-induced neurotoxicity, evident as cen-
tral and peripheral nervous system effects, from both acute and
chronic inhaled exposure among highly exposed workers. Acute
effects include feeling drunk and tiredness (Checkoway et al.
1992), whereas impaired vision (Gobba et al. 1995; Kishi et al.
2001), vestibular dysfunction (Toppila et al. 2006), headaches
(Edling et al. 1993), delayed reaction time (Jégaden et al. 1993;
Tsai and Chen 1996), impaired attention and memory (Cherry and
Gautrin 1990), diminished hearing (Johnson et al. 2006) and nerve
conduction velocity (Cherry and Gautrin 1990; Matikainen et al.
1993; Murata et al. 1994; Rosén et al. 1978; Stetkarova et al.
1993), and abnormal electroencephalogram results (Matikainen
et al. 1993; Seppäläinen and Härkönen 1976) are likely persistent,
chronic effects. These effects have been observed at lower occupa-
tional exposure levels in many (Edling et al. 1993; Flodin et al.
1989; Gobba et al. 1995; Jégaden et al. 1993; Mutti et al. 1984;
Papaleo et al. 2011; Tsai and Chen 1996; Tsai et al. 1997; Viaene
2001), but not all (Rebert and Hall 1994; Triebig et al. 1989),
studies.
A dopaminergic mechanism for styrene neurotoxicity remains
the leading mechanistic hypothesis, although it is speculative
(Costa 1996). Studies suggest that styrene exposure decreases do-
pamine levels and increases dopamine receptors in rodents and
humans (Gagnaire et al. 2006; Jarry et al. 2002; Mutti and
Smargiassi 1998). In blood samples of styrene-exposed plastics
workers, prolactin levels were elevated, indicating reduced pro-
lactin inhibition by dopamine (Luderer et al. 2004). Consistent
with disturbance of the dopaminergic functions of the brain,
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styrene exposure potentiates a dose-dependent decrease in brain
dopamine in male rats (Mutti and Smargiassi 1998), as well as
cell loss and dopamine depletion in retinas isolated from female
rats (Vettori et al. 2000). This finding supports the established
association between occupational styrene exposure and impaired
vision (Gong et al. 2002).
An important strength of the present study was the use of well-
validated, quantitative measures of sensory and motor function
which may detect toxicological effects earlier in disease progres-
sion than clinical assessments detect (Ferreira Ade and Baracat
2014; Gerr et al. 2000). We used a broad test battery, assessingmul-
tiple domains of sensory andmotor function in a clinical research set-
ting. Reliability of these tests (using a protocol and equipment
similar to that in the present study) has been reported previously. The
test–retest correlation coefficients for measurement of vibrotactile
threshold of the dominant toe and nondominant toe were 0.97 and
0.91 among a convenience sample of healthy volunteers (Gerr and
Letz 1988). Further, strong associations were observed between
vibrotactile threshold measurements and a clinician’s blinded
ratings of vibration perception among a sample of patients
referred for evaluation of peripheral nerve disease. A correlation
coefficient of 0.68 was observed between vibrotactile threshold
of the toe and a standard electrophysiological measure of the tib-
ial nerve. In this study sample, at an assigned specificity of 90%,
the sensitivity of the vibrotactile threshold for identifying distal
axonopathy was 86% (Gerr et al. 1991). Test–retest correlation
coefficients for sway speed among healthy volunteers were 0.92
and 0.96 for trials with eyes open and closed, respectively (Letz
1995). Test–retest correlation coefficients for handgrip strength
dynamometry ranged between 0.94 and 0.97 (excluding persons
with known neurological impairment), and were slightly lower
(0.90) among those with known neurological impairment
(Peolsson et al. 2001). For visual contrast sensitivity, the test–
retest correlation coefficient was 0.87 among a small sample of
healthy persons tested on several occasions (Hohberger et al.
2007). We collected these quantitative measures of neurological
health outcomes from among over 3,000 participants, providing
sufficient statistical power to detect small differences in sensory
and motor function relevant to the observed ambient exposure
range. GuLF STUDY participants arise from an understudied,
diverse population (Goldstein et al. 2011), for whom we had
detailed exposure and outcome information.
Associations were not entirely consistent between blood and
ambient exposure metrics, which may be attributable to the
unique limitations of biomarkers and proxy exposures, or the
temporal windows they reflect. Biomarkers of exposure poten-
tially introduce confounding bias, whereas ambient proxy esti-
mates may be subject to measurement error and exposure
misclassification (Weisskopf and Webster 2017). Our study
attempted to address this tradeoff by assessing both types of ex-
posure metrics. We used NATA estimates to represent typical
long-term environmental exposure, and blood styrene measure-
ments to capture internal exposure burdens resulting from recent
exposures. NATA estimates have previously been used as indica-
tors of air pollution exposure in epidemiologic studies of autism
spectrum disorder (Kalkbrenner et al. 2010; Roberts et al. 2013;
Talbott et al. 2015) and neurodegenerative diseases (Malek et al.
2015). Blood styrene is a validated biomarker specific to styrene
exposure (CDC 2013) and it has been used extensively in occupa-
tional research (IARC 2002), as well as in general population
monitoring (ATSDR 2010).
In the Relationships of Indoor, Outdoor, and Personal Air
(RIOPA) study, blood styrene demonstrated stronger correlation
with indoor than with outdoor air concentrations, but outdoor
sources explained more variability in levels than did indoor
sources (Batterman et al. 2014; Su et al. 2013). Indeed, we
observed a lack of concordance between measured blood styrene
and NATA estimated annual average concentrations. At low
occupational styrene levels measured in air, blood, and urine,
blood demonstrated the highest correlations with recent ambient
exposures (Ong et al. 1994).
The main limitations of our study revolved around temporal
factors related to study design and data collection. Our study was
limited by the cross-sectional design, and subsequent inability to
establish temporality between styrene exposure and sensory and
motor performance, though results are unlikely to have been sub-
jected to substantial error by the limitations of cross-sectional
study design. Additionally, we obtained only a single blood mea-
surement for each individual, whereas repeated measures would
potentially improve estimation of usual exposure. Samples for
blood styrene concentrations were obtained 2 to 4 y prior to neu-
rologic testing, and estimated ambient styrene exposure was
assigned using residential address at enrollment (1 to 5 y before
neurologic testing), the timing of which aligns with the most
recent available NATA data. The timing of exposure ascertain-
ment for both styrene metrics may introduce misclassification,
depending on the relevant timing of exposure. Further, we did
not account for duration of residence at the enrollment address
that was used to assign ambient exposure.
Covariate information was obtained at enrollment or the time of
the blood draw and may not be reflective of immediate confounding
exposures near the time of the neurologic testing. As such, the possi-
bility that potential confounders changed between exposure and out-
come ascertainment may have introduced residual confounding.
Another possible source of residual confounding is the crude categori-
zation of employment, which is intended to account for confounding
by socioeconomic status and general health status (being healthy
enough to work), but not necessarily to provide insight into specific
work-related exposures. We previously examined detailed work-
related information in this population to identify possible occupa-
tional styrene exposure opportunities but ultimately found those to be
negligible (Werder et al. 2018). Unemployed participants were simi-
lar to the overall population with respect to age and gender. We
acknowledge the heterogeneity in this crude categorization of
employment, recognizing that it is not a perfect measure of socioeco-
nomic or health status.We believe, however, that it is a useful indica-
tor among these individuals who were available to complete training
for Deepwater Horizon oil-spill response efforts. Further, simultane-
ous adjustment for employment and educational attainment likely
ameliorates confounding by social factors in this unique population.
Using an annual average ambient concentration limits inter-
pretation. However, as routine monitoring of ambient styrene in
the United States does not provide sufficient temporal or spatial
coverage to support exposure interpolation methods (Li and Heap
2011; Whitworth et al. 2011; Wong et al. 2004), NATA remains
the only spatially referenced exposure data source with sufficient
geographic coverage for our study region. Although the assump-
tions inherent to an annual average estimate of air pollution
potentially limit interpretation, NATA data are a valid estimation
of usual exposure levels experienced by Gulf region residents.
Long-term blood and ambient styrene trends indicate that year-
to-year regional variation in concentration is generally not sub-
stantial, suggesting that an annual average estimate is an appro-
priate assessment of exposure (Ashley et al. 1994; CDC 2013;
Churchill et al. 2001; Cohen et al. 2002). If long-term styrene ex-
posure exerts chronic sensory or motor effects, NATA estimates
may be a more relevant exposure metric than measures with
more precise temporal windows.
Although styrene-associated impairment of sensory and motor
function was not universally apparent across all exposure and
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outcome measures, in aggregate, our results are suggestive of a
neurotoxic effect of styrene. The standing steadiness and vibro-
tactile threshold tests are well-established and validated measures
of neurologic performance with known standard covariates
(Ferreira Ade and Baracat 2014; Gerr and Letz 1994a, 1994b).
Testing sensory function in this way may allow for early detec-
tion of subclinical neurotoxicity among groups exposed at levels
relevant to the general population. Furthermore, large fiber func-
tion abnormality may be an early indicator of neurological dis-
ease. Future research is needed to confirm these findings and to
determine whether styrene-induced neurotoxicity derived from
environmental exposures persists over time, and how it may
relate to future risk of clinically apparent neurological disease.
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